Wall Street
Price Targets

CD5N Price Targets Summary
Inuvo Inc

Wall Street analysts forecast CD5N stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CD5N is 16.74 EUR with a low forecast of 15.25 EUR and a high forecast of 19.02 EUR.

Lowest
Price Target
15.25 EUR
281% Upside
Average
Price Target
16.74 EUR
319% Upside
Highest
Price Target
19.02 EUR
375% Upside
Inuvo Inc Competitors:
Price Targets
REKR
Rekor Systems Inc
110% Upside
SEMR
SEMrush Holdings Inc
1% Upside
VERI
Veritone Inc
127% Upside
PROF
Profile Systems and Software SA
5% Upside
SPSC
SPS Commerce Inc
12% Upside
MITK
Mitek Systems Inc
29% Upside
AVPT
AvePoint Inc
46% Upside

Revenue
Forecast

Revenue Estimate
Inuvo Inc

For the last 13 years the compound annual growth rate for Inuvo Inc's revenue is 7%. The projected CAGR for the next 2 years is 18%.

7%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Inuvo Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Inuvo Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CD5N's stock price target?
Price Target
16.74 EUR

According to Wall Street analysts, the average 1-year price target for CD5N is 16.74 EUR with a low forecast of 15.25 EUR and a high forecast of 19.02 EUR.

What is Inuvo Inc's Revenue forecast?
Projected CAGR
18%

For the last 13 years the compound annual growth rate for Inuvo Inc's revenue is 7%. The projected CAGR for the next 2 years is 18%.

Back to Top